| HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
| MEG3 |
|
maternally expressed 3
|
|
|
0.471 |
0.846 |
| MIR137 |
|
microRNA 137
|
|
|
0.513 |
0.846 |
| AAVS1 |
|
adeno-associated virus integration site 1
|
|
|
0.595 |
0.731 |
| BDNF-AS |
|
BDNF antisense RNA
|
|
|
0.638 |
0.538 |
| MIR219A1 |
|
microRNA 219a-1
|
|
|
0.595 |
0.615 |
| MIR379 |
|
microRNA 379
|
|
|
0.615 |
0.538 |
| FRAXA |
|
fragile site, folic acid type, rare, fra(X)(q27.3) A (macroorchidism, mental retardation)
|
|
|
0.641 |
0.462 |
| FRAXE |
|
fragile site, folic acid type, rare, fra(X)(q28) E
|
|
|
0.636 |
0.462 |
| PRS |
|
Prieto X-linked mental retardation syndrome
|
|
|
0.663 |
0.615 |
| RLS1 |
|
Restless legs syndrome, susceptibility to
|
|
|
0.705 |
0.423 |
| MDD1 |
|
Major depressive disorder
|
|
|
0.682 |
0.308 |
| ERICD |
|
E2F1-regulated inhibitor of cell death
|
|
|
0.691 |
0.654 |
| SNORD116@ |
|
small nucleolar RNA, C/D box 116 cluster
|
|
|
0.705 |
0.692 |
| PTLS |
|
Potocki-Lupski syndrome
|
|
|
0.780 |
0.308 |
| EJM2 |
|
epilepsy, juvenile myoclonic 2
|
|
|
0.751 |
0.192 |
| PTCHD1-AS |
|
PTCHD1 antisense RNA (head to head)
|
|
|
0.839 |
0.308 |
| MACROD2 |
A1Z1Q3
|
mono-ADP ribosylhydrolase 2
|
|
0.43 |
0.686 |
0.423 |
| PSD |
A5PKW4
|
pleckstrin and Sec7 domain containing
|
|
0.90 |
0.626 |
0.654 |
| RBFOX3 |
A6NFN3
|
RNA binding fox-1 homolog 3
|
Nucleic acid binding
|
1.00 |
0.751 |
0.192 |
| WASHC1 |
A8K0Z3
|
WASH complex subunit 1
|
|
|
0.780 |
0.308 |
| FZD9 |
O00144
|
frizzled class receptor 9
|
G-protein coupled receptor
|
1.9E-03 |
0.743 |
0.308 |
| AP4M1 |
O00189
|
adaptor related protein complex 4 subunit mu 1
|
Extracellular structure
|
4.5E-17 |
0.638 |
0.500 |
| PSMD12 |
O00232
|
proteasome 26S subunit, non-ATPase 12
|
Enzyme modulator
|
1.00 |
0.578 |
0.808 |
| ARNTL |
O00327
|
aryl hydrocarbon receptor nuclear translocator like
|
Transcription factor
|
0.99 |
0.510 |
0.885 |